ndividuals with scleroderma are living significantly longer today, compared with 30 years ago, and the physicians who treat this rare disease of connective tissue hope the newer drugs now on the market may extend lives even further. Scleroderma, a rare autoimmune disorder of unknown origin, results when collagen builds up in the body’s connective tissue and causes thickening of the skin. In the chronic and often progressive systemic form, scleroderma causes stiff joints and hardening of the in Join discussion...